Barbora Belšánová

420 total citations
22 papers, 327 citations indexed

About

Barbora Belšánová is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbora Belšánová has authored 22 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbora Belšánová's work include Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Barbora Belšánová is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Barbora Belšánová collaborates with scholars based in Czechia, Netherlands and Germany. Barbora Belšánová's co-authors include Marek Minárik, Lucie Benešová, Miloš Pešek, Miroslav Zavoral, Ludmila Lipská, Miroslav Levý, Štěpán Suchánek, V. Visokai, Ondřej Fiala and Tereza Hálková and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Barbora Belšánová

21 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbora Belšánová Czechia	8	177	172	160	128	67	22	327
Takako Okuyama Japan	5	167 0.9×	268 1.6×	259 1.6×	113 0.9×	59 0.9×	12	354
Itziar de Aguirre Spain	9	155 0.9×	140 0.8×	178 1.1×	193 1.5×	68 1.0×	21	388
Fatima Fuerte Philippines	2	199 1.1×	319 1.9×	331 2.1×	76 0.6×	59 0.9×	3	389
Isabel Heidrich Germany	8	172 1.0×	192 1.1×	67 0.4×	128 1.0×	42 0.6×	18	321
Guia Ladrera Thailand	4	232 1.3×	322 1.9×	364 2.3×	85 0.7×	59 0.9×	4	423
Jennifer Sandoval-Tan Philippines	6	238 1.3×	339 2.0×	361 2.3×	97 0.8×	82 1.2×	9	475
Anna Buder Austria	9	169 1.0×	192 1.1×	255 1.6×	99 0.8×	27 0.4×	16	325
Eisaku Furukawa Japan	5	173 1.0×	184 1.1×	78 0.5×	99 0.8×	80 1.2×	7	274
Xiaofang Xing China	9	191 1.1×	140 0.8×	102 0.6×	188 1.5×	22 0.3×	15	386
Xiuju Du China	4	159 0.9×	124 0.7×	158 1.0×	128 1.0×	28 0.4×	4	307

Countries citing papers authored by Barbora Belšánová

Since Specialization

Citations

This map shows the geographic impact of Barbora Belšánová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbora Belšánová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbora Belšánová more than expected).

Fields of papers citing papers by Barbora Belšánová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbora Belšánová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbora Belšánová. The network helps show where Barbora Belšánová may publish in the future.

Co-authorship network of co-authors of Barbora Belšánová

This figure shows the co-authorship network connecting the top 25 collaborators of Barbora Belšánová. A scholar is included among the top collaborators of Barbora Belšánová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbora Belšánová. Barbora Belšánová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minárik, Marek, Lucie Benešová, Tereza Hálková, et al.. (2020). Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response. Frontiers in Oncology. 10. 1028–1028. 31 indexed citations

Benešová, Lucie, et al.. (2018). Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer. Pathology & Oncology Research. 26(1). 379–385. 6 indexed citations

Klepárnı́k, Karel, et al.. (2018). Capillary electrophoresis, a method for the determination of nucleic acid ligands covalently attached to quantum dots representing a donor of Förster resonance energy transfer. Journal of Separation Science. 41(14). 2961–2968. 7 indexed citations

Benešová, Lucie, et al.. (2018). Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumors. Journal of Separation Science. 41(13). 2819–2827. 4 indexed citations

Minárik, Marek, Barbora Belšánová, Ondřej Fiala, Miloš Pešek, & Lucie Benešová. (2017). Validation of the denaturing capillary electrophoresis (DCE) assay for non-invasive liquid biopsy in lung carcinoma: A study of concordance with the cobas EGFR mutation test v2.. Journal of Clinical Oncology. 35(15_suppl). e23040–e23040. 1 indexed citations

Benešová, Lucie, Barbora Belšánová, Miroslav Levý, et al.. (2016). Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery. Advances in Clinical and Experimental Medicine. 25(6). 1273–1279. 7 indexed citations

Benešová, Lucie, Tereza Hálková, Barbora Belšánová, et al.. (2016). Longitudinal molecular characterization of endoscopic specimens from colorectal lesions. World Journal of Gastroenterology. 22(20). 4936–4936. 4 indexed citations

Belšánová, Barbora, et al.. (2016). Genetic and Epigenetic Factors Affecting  Development and Prognosis of Brain Gliomas – a Review of Current Knowledge. Česká a slovenská neurologie a neurochirurgie. 79/112(4). 400–405. 1 indexed citations

Minárik, Marek, et al.. (2016). Abstract 4943: Detection of specific KRAS mutation type, Gly12Asp (GGT>GAT), in EUS-guided fine needle aspiration cytology (EUS-FNAC) identifies pancreatic cancer patients with poor prognosis. Cancer Research. 76(14_Supplement). 4943–4943. 1 indexed citations

10.

Čurila, Karol, Lucie Benešová, Pavol Tomašov, et al.. (2015). Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy. Cardiology. 130(3). 137–142. 2 indexed citations

11.

Poole, Jason C., Cecile Rose T. Vibat, Lucie Benešová, et al.. (2015). Highly sensitive quantitative detection of circulating tumor DNA in urine and plasma from advanced colorectal cancer patients in aid of early diagnosis of clinically relevant KRAS mutations.. Journal of Clinical Oncology. 33(3_suppl). 654–654. 2 indexed citations

12.

Benešová, Lucie, Barbora Belšánová, Tereza Hálková, et al.. (2015). Evaluation of circulating-tumor DNA (ctDNA) as a source material for molecular phenotyping of colorectal tumors.. Journal of Clinical Oncology. 33(3_suppl). 642–642. 2 indexed citations

13.

Tomašov, Pavol, Marek Minárik, David Zemánek, et al.. (2014). Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy. Folia Biologica. 60(1). 28–34. 5 indexed citations

14.

Fiala, Ondřej, Miloš Pešek, Jindřich Fínek, et al.. (2013). The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer. Cancer Genetics. 206(1-2). 26–31. 44 indexed citations

15.

Benešová, Lucie, Barbora Belšánová, Štěpán Suchánek, et al.. (2012). Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Analytical Biochemistry. 433(2). 227–234. 89 indexed citations

16.

Levý, Miroslav, Lucie Benešová, Ludmila Lipská, et al.. (2012). Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients.. PubMed. 32(5). 1621–6. 20 indexed citations

17.

Minárik, Marek, Barbora Belšánová, Ludmila Lipská, et al.. (2011). Circulating Free Tumor DNA in Patient Plasma is a Near-Perfect Marker for Metastatic Spread of Colorectal Cancer: A Study on 165 Patients Undergoing Surgical Treatment. Gastroenterology. 140(5). S–343. 1 indexed citations

18.

Minárik, Marek, Barbora Belšánová, Miloš Pešek, et al.. (2010). A novel high‐resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA. Electrophoresis. 31(21). 3518–3524. 9 indexed citations

19.

Benešová, Lucie, et al.. (2010). Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy. Journal of Separation Science. 33(15). 2349–2355. 7 indexed citations

20.

Pešek, Miloš, et al.. (2009). Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.. PubMed. 29(7). 2767–73. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact